| pubmed-article:16675096 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16675096 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16675096 | lifeskim:mentions | umls-concept:C0007134 | lld:lifeskim |
| pubmed-article:16675096 | lifeskim:mentions | umls-concept:C0011306 | lld:lifeskim |
| pubmed-article:16675096 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
| pubmed-article:16675096 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
| pubmed-article:16675096 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16675096 | pubmed:dateCreated | 2006-6-13 | lld:pubmed |
| pubmed-article:16675096 | pubmed:abstractText | Dendritic cell (DC) vaccination against cancer is a new specific immunotherapeutic approach given with either therapeutic or adjuvant intent. We provide a review of DC vaccination as a treatment for metastatic renal cell carcinoma (RCC). | lld:pubmed |
| pubmed-article:16675096 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675096 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16675096 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675096 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16675096 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675096 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675096 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16675096 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16675096 | pubmed:issn | 0302-2838 | lld:pubmed |
| pubmed-article:16675096 | pubmed:author | pubmed-author:GeertsenPoul... | lld:pubmed |
| pubmed-article:16675096 | pubmed:author | pubmed-author:SvaneInge... | lld:pubmed |
| pubmed-article:16675096 | pubmed:author | pubmed-author:BerntsenAnnik... | lld:pubmed |
| pubmed-article:16675096 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16675096 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:16675096 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16675096 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16675096 | pubmed:pagination | 34-43 | lld:pubmed |
| pubmed-article:16675096 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:meshHeading | pubmed-meshheading:16675096... | lld:pubmed |
| pubmed-article:16675096 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16675096 | pubmed:articleTitle | Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. | lld:pubmed |
| pubmed-article:16675096 | pubmed:affiliation | Department of Oncology, Herlev University Hospital, Herlev, Denmark. berntsen@dadlnet.dk | lld:pubmed |
| pubmed-article:16675096 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675096 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675096 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675096 | lld:pubmed |
